🧫

Nrf2 inhibitor ML385 mechanism validation experiment

experiment Created: 2026-04-10 22:49:03 By: experiment_extractor Quality: 85% ✓ SciDEX ID: experiment-exp-25159d1d-2d48-4bb0-bfb1-c
🧫 Experiment Protocol Cell Biology
🧫 View Full Experiment Page →
Related Entities
Nrf2
Metadata
experiment_typecell_biology
protocolco-treatment with acteoside and ML385, assessment of ferroptosis markers
expected_outcomesML385 blocks acteoside's anti-ferroptotic effects
success_criterialoss of acteoside's anti-ferroptotic activity when Nrf2 is inhibited
sample_sizeNone
statistical_methodsNone
p_valueNone
effect_sizeNone
extracted_at2026-04-10T15:49:03.770060
source_pmid41895086
_origin{'type': 'internal', 'url': None, 'tracked_at': '2026-04-10T22:49:03.899932'}
🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

Linked Artifacts (122)
related🧫Acteoside treatment in LPS-induced SALI mouse model100%
related🧫Acteoside effects on RAW264.7 macrophage cells100%
mentions📖NRF2 Gene80%
mentions📖NRF2 Activator Therapy80%
mentions📖NRF2 Therapeutics: Investment Landscape Analysis80%
mentions📖NRF2 Activators for Parkinson's Disease80%
mentions📖NRF2-KEAP1 Oxidative Stress Response Pathway80%
mentions📖NRF2 Oxidative Stress Pathway80%
mentions📖NRF2 Signaling Pathway in Neurodegeneration80%
mentions📖nrf280%
mentions📖NRF2 Activator Therapy for Neurodegeneration80%
mentions📖NRF2 Activators in Neurodegenerative Disease80%
mentions📖nrf2-activators-parkinsons-disease80%
related📖NRF2 Gene72%
related📖NRF2 Activator Therapy72%
related📖NRF2 Therapeutics: Investment Landscape Analysis72%
related📖NRF2 Activators for Parkinson's Disease72%
related📖NRF2-KEAP1 Oxidative Stress Response Pathway72%
related📖NRF2 Oxidative Stress Pathway72%
related📖NRF2 Signaling Pathway in Neurodegeneration72%
related📖nrf272%
related📖NRF2 Activator Therapy for Neurodegeneration72%
related📖NRF2 Activators in Neurodegenerative Disease72%
related📖nrf2-activators-parkinsons-disease72%
mentions📖Ferroptosis60%
related📓Nutrient-Sensing Epigenetic Circuit Reactivation — Computati60%
related📖Ferroptosis in Neurodegeneration55%
related📖Ferroptosis54%
mentions📖Transcriptional Regulation in Neurodegeneration50%
mentions📖MDS 2026: Neuroprotection and Neurorestorative Strategies fo50%
mentions📖Neuroimmune Checkpoint-Metal-Oxidative Stress Convergence Sy50%
mentions📖SQSTM1/p6250%
mentions📖Ferroptotic Neurons50%
mentions📖Oxidative Stress in Corticobasal Syndrome50%
mentions📖Nrf2 Activators for Neurodegenerative Diseases50%
mentions📖Oxidative Stress Response in 4R-Tauopathies50%
mentions📖Progressive Supranuclear Palsy (PSP)50%
mentions📖Substantia Nigra Dopamine Neurons in Aceruloplasminemia50%
mentions📖Dopaminergic Substantia Nigra Neurons in Parkinson's Di50%
mentions📖chemotherapy-resistance50%
mentions📖PPAR (Peroxisome Proliferator-Activated Receptor)50%
mentions📖Reactive Oxygen Species (ROS)50%
mentions📖GLP-1 Receptor Agonists — Investment Landscape Analysis50%
mentions📖Circadian Rhythm in Neurodegeneration50%
mentions📖dna-damage-repair50%
mentions📖oxidative-stress-comparison50%
mentions📖combination-therapy-cbs-psp50%
mentions📖PGC-1α Activator Therapy for Neurodegeneration50%
mentions📖Section 162: Advanced Antioxidant and Redox Therapy in CBS/P50%
mentions📖Alpha-Synuclein Seed Kinetic Staging in Parkinson's Dis50%
mentions📖Astrocytes in Brain Homeostasis50%
mentions📖dimethyl-fumarate-nrf2-ad-nct0685059750%
mentions📖nct06365190-rtms-pd50%
mentions📖Tumor Necrosis Factor (TNF)50%
mentions📖Ferroptosis in Neurodegeneration50%
mentions📖Ferroptosis in Alzheimer's Disease50%
mentions📖Hypoxia Neuroprotection in Sporadic Parkinson's Disease50%
mentions📖Nrf2 Signaling in Neurodegeneration50%
mentions📖Ubiquitin-Proteasome System in Alzheimer's Disease Path50%
mentions📖Digital Therapeutics for Parkinson's Disease50%
mentions📖alpha-lipoic-acid-neurodegeneration50%
mentions📖Stress Granule Dysfunction Hypothesis in Parkinson's Di50%
mentions📖Sulforaphane and Nrf2 Activation for Neuroprotection50%
mentions📖Personalized Treatment Plan — Atypical Parkinsonism (CBS/PSP50%
mentions📖Pramipexole Early Parkinson's Trial50%
mentions📖Novel Therapy Index50%
mentions📖Multi-Target Pharmacotherapy and Network Pharmacology for CB50%
mentions📖Corticobasal Syndrome (CBS)50%
mentions📖dopaminergic-vta-pd44%
mentions📖Dorsal Raphe Serotonergic Neurons in Parkinson's Diseas44%
mentions📖Globus Pallidus Internus in Parkinsons Disease44%
mentions📖Melanocytes in Parkinson Disease44%
mentions📖Nigrostriatal Dopamine Terminals in Parkinson's Disease44%
mentions📖Vulnerable Dopaminergic Neurons in Parkinson's Disease44%
mentions📖AB-1005 (REGENERATE-PD) GDNF Gene Therapy Trial44%
mentions📖Apocynin for Parkinson's Disease44%
mentions📖Bacillus Subtilis for Parkinson Disease (NCT06487975)44%
mentions📖biib122-luma-lrrk2-inhibitor-pd44%
mentions📖CT1-DAP001 iPS Cell-derived Dopaminergic Progenitors for Par44%
mentions📖Intranasal Insulin and Glutathione for PD (NOSE-PD)44%
mentions📖NCT05565443: MR-Guided Focused Ultrasound + GCase for Parkin44%
mentions📖nct05266417-nose-pd44%
mentions📖Autologous Stem Cell-Derived Dopaminergic Neurons for Parkin44%
mentions📖Dyadic Mindfulness for PD Carers (NCT06821230)44%
mentions📖Amino Acid Supplement in Parkinson's Disease (NCT06954644%
mentions📖Vibrotactile Stimulation Walking Speed PD Trial44%
mentions📖NouvNeu001 Cell Therapy for Parkinson's Disease44%
mentions📖PDE4 Inhibitor PD Trial44%
mentions📖Retigabine PD Trial44%
mentions📖Valacyclovir for HSV-1-Positive Parkinson's Disease44%
mentions📖NCT05881460: Vibrotactile Coordinated Reset for Parkinson&#x44%
mentions📖AMP-PD: Accelerating Medicines Partnership: Parkinson's44%
mentions📖Alpha-Synuclein SAA Kinetics Study — Biological Staging Back44%
mentions📖Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio44%
mentions📖Alpha-Synuclein Spreading Mechanism — Prion-Like Propagation44%
mentions📖Combination Therapy Sequencing in Parkinson's Disease44%
mentions📖Selective Vulnerability of Dopaminergic Neurons — Mechanism 44%
mentions📖GLP-1 Agonist Responder Prediction Study — Precision Medicin44%
mentions📖Synaptic Mitochondrial Resilience Enhancement for Parkinson&44%
mentions📖HSP70 Inducer Therapies44%
mentions📖Glucocorticoid Receptor Modulation Therapy for Neurodegenera44%
mentions📖Oxidative Stress Therapeutics: Investment Landscape Analysis44%
mentions📖Oxidative Stress Therapeutics Investment Landscape44%
mentions📖DNA Damage Response and Repair in Neurodegeneration44%
mentions📖Ferroptosis Pathway in Neurodegeneration44%
mentions📖GDF15/GDF11 Signaling in Neurodegeneration44%
mentions📖Microglial Metabolic Reprogramming44%
mentions📖Mitochondrial Dysfunction Hub44%
mentions📖MLCS Quantification Methods in Parkinson's Disease Rese44%
mentions📖Reactive Oxygen Species (ROS) Pathway44%
mentions📖AI-Powered Movement Analysis for Parkinson's Disease44%
mentions📖Digital Biomarker Platforms for Parkinson's Disease44%
mentions📖Wearable Sensors for Parkinson's Disease44%
mentions📖Adenosine A2A Receptor Antagonists44%
mentions📖CUE1 Non-Invasive Vibrotactile Device for Parkinson's D44%
mentions📖Ferulic Acid Carbamate Derivatives for Alzheimer's Dise44%
mentions📖Memantine - NMDA Antagonist for Alzheimer's Disease44%
mentions📖NURR1 Agonist Therapy for Parkinson's Disease44%
mentions📖Synaptic Plasticity Therapeutics for Parkinson's Diseas44%
mentions📖tfeb-activators-neurodegeneration44%
mentions📖TGR5 Agonist Therapy44%
related📓Nutrient-Sensing Epigenetic Circuit Reactivation — Computati12%

💬 Discussion